Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:II-247-II-256

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomita, S.
Right arrow Articles by Jia, Z.-Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomita, S.
Right arrow Articles by Jia, Z.-Q.
Related Collections
Right arrow Contractile function
Right arrow Angiogenesis
Right arrow Cell biology/structural biology
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 1999;100:II-247.)
© 1999 American Heart Association, Inc.


Thoracic Transplantation and Ventricular Assist Devices

Autologous Transplantation of Bone Marrow Cells Improves Damaged Heart Function

Shinji Tomita, MD; Ren-Ke Li, MD, PhD; Richard D. Weisel, MD; Donald A. G. Mickle, MD; Eung-Joong Kim, MD; Tetsuro Sakai, MD; Zhi-Qiang Jia, MD

From the Department of Surgery, Division of Cardiovascular Surgery, The Toronto Hospital-General Division, University of Toronto, Ontario, Canada.

Background—Autologous bone marrow cells (BMCs) transplanted into ventricular scar tissue may differentiate into cardiomyocytes and restore myocardial function. This study evaluated cardiomyogenic differentiation of BMCs, their survival in myocardial scar tissue, and the effect of the implanted cells on heart function.

Methods and Results—In vitro studies: BMCs from adult rats were cultured in cell culture medium (control) and medium with 5-azacytidine (5-aza, 10 µmol/L), TGFß1 (10ng/mL), or insulin (1 nmol/L) (n=6, each group). Only BMCs cultured with 5-aza formed myotubules which stained positively for troponin I and myosin heavy chain. In vivo studies: a cryoinjury-derived scar was formed in the left ventricular free wall. At 3 weeks after injury, fresh BMCs (n=9), cultured BMCs (n=9), 5-aza–induced BMCs (n=12), and medium (control, n=12) were autologously transplanted into the scar. Heart function was measured at 8 weeks after myocardial injury. Cardiac-like muscle cells which stained positively for myosin heavy chain and troponin I were observed in the scar tissue of the 3 groups of BMC transplanted hearts. Only the 5-aza–treated BMC transplanted hearts had systolic and developed pressures which were higher (P<0.05) than that of the control hearts. All transplanted BMCs induced angiogenesis in the scar.

Conclusions—Transplantation of BMCs induced angiogenesis. BMCs cultured with 5-aza differentiated into cardiac-like muscle cells in culture and in vivo in ventricular scar tissue and improved myocardial function.


Key Words: cells • myocardial infarction • transplantation • angiogenesis • myocardial contraction